Hostname: page-component-cb9f654ff-mx8w7 Total loading time: 0 Render date: 2025-07-31T09:44:29.230Z Has data issue: false hasContentIssue false
  • English
  • Français

The Efficacy and Safety of 28-day Treatment with Ziprasidone in Schizophrenia/schizoaffective Disorder

Published online by Cambridge University Press:  16 April 2020

E. Harrigan  and
Ziprasidone Working Group
E. Harrigan
Affiliation:
Department of Clinical Research, Pfizer Central Research, GrotonCT 06340, USA

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Submit a response

Comments

No Comments have been published for this article.